About Viatris Inc.
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.
2BB score and signals
Viatris Inc.’s current 2BB score is 34 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 43 | Moderate |
| Momentum | 63 | Improving |
| Financial strength | 51 | Normal |
| Quality | 96 | Very Strong |
| Risk | 23 | Low |
Company facts
| CEO | Scott A. Smith |
| Headquarters | Canonsburg, Pennsylvania, United States |
| Founded | Nov 16, 2020 |
| Employees | 30K |
| 52-week range | $9.86 – $18.43 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | 0.6097 | — | $3.80B |
| 2026-11-05 | — | 0.6522 | — | $3.87B |
| 2026-08-06 | — | 0.6129 | — | $3.75B |
| 2026-05-07 | 0.59 | 0.5123 | $3.52B | $3.42B |
Related companies
